Zhejiang Jingxin Pharmaceutical Co Ltd
002020
Company Profile
Business description
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
Contact
No.800 Xinchang East Road
Yulin subdistrict
Zhejiang Province
Xinchang312500
CHNT: +86 57586298518
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,909
Stocks News & Analysis
video
What does the RBA rate cut mean for investors?
Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.
stocks
Insights from reporting season: So far, so good
We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.
stocks
3 cheap ASX stocks owned by top rated funds
Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,570.90 | 30.80 | -0.36% |
| CAC 40 | 8,154.51 | 31.93 | 0.39% |
| DAX 40 | 22,287.56 | 27.09 | -0.12% |
| Dow JONES (US) | 43,428.02 | 748.63 | -1.69% |
| FTSE 100 | 8,659.37 | 3.60 | -0.04% |
| HKSE | 23,477.92 | 900.94 | 3.99% |
| NASDAQ | 19,524.01 | 438.36 | -2.20% |
| Nikkei 225 | 38,776.94 | 98.90 | 0.26% |
| NZX 50 Index | 12,752.58 | 127.78 | -0.99% |
| S&P 500 | 6,013.13 | 104.39 | -1.71% |
| S&P/ASX 200 | 8,296.20 | 26.60 | -0.32% |
| SSE Composite Index | 3,379.11 | 28.33 | 0.85% |